-BK38, PRCYTA-40K-PX48, PRCYTA-40K-BK48
Control Catalog # PRCYTA-6040-1 Lot # A6041-103 and A6041-203
***Additional Analytes on reverse side***
Note: The Quality Control Ranges are generated with
(2001)
4. Garner, C.C. and Matus, A.J., J. Cell Biol., 106,
779-783 (1983).
5. Bernhardt, R. and Matus, A.J., J. Comp. Neurol.,
226, 203-219 (1984).
6. Riederer, B.
Coronary Atherectomy. ATHEROSCLEROSIS.130:
203-213, 1997.
6. Metzger et al. CD 143 in the development of atherosclerosis. ATHEROSCLEROSIS,
150:21-31, 2000.
7. Metzger R. et al. Distribution of Angiotensin
and Noltman, E.A., in The Enzymes, vol. 6, 2nd ed. Boyer, P.D., ed., p. 106 (1962).
2. Noda, L. et al., J. Biol. Chem., 209, 203 (1954).
3. Eppenberger, H.M. et al., J. Biol. Chem., 242, 204 (1967).
Biochem. Biophys. Acta., 1492
203 (2000).
6. Bernard, O., and Matthew, P., Guidebook to
Cytokines and Their Receptors, Oxford Press,
(New York, NY: 1994).
7. Galzie, Z., et al., Biochem. Cell
RECOMMENDED
ASSAY CONDITIONS:
for 5 min. Resuspend cells at 5 x 106 cells/mL in Freezing Media (cell densities of 2-10
x 106 are also acceptable if necessary). Dispense 1 mL aliquots into cryopreservation
seeding on microfluidic plates
After loading 100 µL of the cell solution (0.5 x 106 cells/
mL) to Well 6 and 50 µL to Well 7, the plates were placed
on a tilting rack at a 45 degree decline. Plates were
hospitalisation and a novel MRI-based diagnostic
tool". University of Birmingham, Ph D.
dissertation, p. 203 (2016).
14. Chalari, Eleanna, "The effect of high-intensity
intermittent exercise on biomarkers
concentration to ∼1 × 106 viable cells
per mL.
2. For the entire 96 well plate, mix 14.8 mL of Culture
Medium without puromycin with 4.2 mL of the cell
suspension (step 1, ∼1 × 106 viable
concentration to ∼1 × 106 viable cells
per mL.
2. For the entire 96 well plate, mix 14.8 mL of Culture
Medium without puromycin with 4.2 mL of the cell
suspension (step 1, ∼1 × 106 viable
concentration to ∼1 × 106 viable cells
per mL.
2. For the entire 96 well plate, mix 14.8 mL of Culture
Medium without puromycin with 4.2 mL of the cell
suspension (step 1, ∼1 × 106 viable
concentration to ∼1 × 106 viable cells
per mL.
2. For the entire 96 well plate, mix 14.8 mL of Culture
Medium without puromycin with 4.2 mL of the cell
suspension (step 1, ∼1 × 106 viable
ES cell derived) 1M
(Cor.At CL-eC-1M)
1 × 106 mouse ES cell derived cells
Catalog Number AXIO0018
Or
(Mouse ES cell derived) 5M
(Cor.At CL-eC-5M)
5 × 106 mouse ES cell derived cells
Catalog Number
ES cell derived) 1M
(Cor.At CL-eC-1M)
1 × 106 mouse ES cell derived cells
Catalog Number AXIO0018
Or
(Mouse ES cell derived) 5M
(Cor.At CL-eC-5M)
5 × 106 mouse ES cell derived cells
Catalog Number
Eng. J. Med.
302:1073-1076.
7. Freij, B. J. and J. L. Sever. 1988. Herpesvirus infections in pregnancy: risk to embryo, fetus and
neonate. Clin. Perinatol. 15:203-231.
8. Alford, C. A. and W
ES cell derived) 1M
(Cor.At GFP-eC-1M)
1 × 106 mouse ES cell derived cells
Catalog Number AXIO0026
Or
(Mouse ES cell derived) 5M
(Cor.At GFP-eC-5M)
5 × 106 mouse ES cell derived cells
Catalog Number